BPAC issues new guidelines for Lamotrigine
Thursday, 26 September 2019
Covid-19 and Epilepsy
Information about Covid-19 for people with epilepsy.
Know what to do when a seizure happens in front of you.
We rely heavily on community support to achieve our goal.
LEAVE A LEGACY
A bequest is an easy way to support Epilepsy New Zealand.
We need your help! If you're interested in fundraising for us, register today!
Epilepsy New Zealand has been receiving regular information from the Ministry of Health and other agencies, often more than once a day, showing just how quickly the situation is evolving. No doubt there will be many people, including those with epilepsy, who have questions around their risk and what to do in these uncertain times. Hopefully the information below may help reassure you and where necessary, prompt you to contact your trusted health professional.
BPAC issues new guidelines for Lamotrigine.
A petition is underway calling on Pharmac to reverse its decision on Lamotrigine.
We opposed this change from Lamictal to Logem from the start, and staff have advocated on behalf of people with epilepsy in discussions with Pharmac.
Adele Hauwai has shared her Living With Epilepsy story as part of the Epilepsy NZ Tell Us About It Competition. People were asked to send in their stories about epilepsy, the challenges they faced and the lessons they have learned that they would like to share with the world.
The ILAE announces the publication in Epilepsia of two new landmark classification documents, one of seizure types and one of the epilepsies.